HCA HCA Healthcare, Inc. Common Stock
NYSE · Health Care · Visualizza su SEC EDGAR ↗ chiudi Ott 6, 2026 10-K/10-Q Lug 28, 2026HCA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
HCA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Informazioni su HCA Healthcare, Inc. Common Stock Panoramica della società da Wikipedia
HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
History
Early years
The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was chief executive.
The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.
Growth and merger
The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.
In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.
In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,
to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.
Columbia Hospital Corporation
In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.
In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.
Recent history
On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.
In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.
In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.
In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.
In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.
In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.
In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.
In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.
Facilities
United States
As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.
Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.
In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.
In 2019 they purchased Mission Health System which operates hospitals in North Carolina.
In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.
In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.
United Kingdom
HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:
It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.
The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.
The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.
Significant areas of operation
Medical education
In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.
Controversies
Medicare billing practices lawsuit
In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.
The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.
2005 insider trading suit
In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.
COVID-19 PPE
During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.
Mission Hospital Acquisition Complaints
On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.
On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | HCA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 14.5media 5 anni ≈13.8 | ≈13.8 | 16.5 | Sottovalutato | |
| P/S (TTM) | 1.2media 5 anni ≈1.2 | ≈1.2 | 1.3 | Sottovalutato | |
| P/B (MRQ) | -14.2media 5 anni ≈-39.2 | ≈-39.2 | · | · | |
| EV / EBITDA | 39.1media 5 anni ≈37.3 | ≈37.3 | 19.6 | Sopravvalutato | |
| Prezzo / FCF (TTM) | 15.7media 5 anni ≈14.6 | ≈14.6 | · | · | |
| Prezzo / Flusso di cassa (TTM) | 8.5media 5 anni ≈7.9 | ≈7.9 | 9.7 | Sottovalutato | |
| EV / Revenue (EV / Ricavi) | 1.8media 5 anni ≈1.8 | ≈1.8 | · | · | |
| EV / FCF | 17.9media 5 anni ≈21.8 | ≈21.8 | · | · | |
| PEG Ratio | ≈0.7 | · | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | HCA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| EBITDA Margin (Margine EBITDA) | 4.7%media 5 anni ≈4.8% | ≈4.8% | 11.1% | Debole | |
| Margine ante imposte (TTM) | 12.7%media 5 anni ≈13.6% | ≈13.6% | 9.8% | Di prim'ordine | |
| Margine di Profitto Netto (TTM) | 8.8%media 5 anni ≈9.3% | ≈9.3% | 7.3% | In linea | |
| ROA (TTM) | 11.1%media 5 anni ≈11.2% | ≈11.2% | 6.5% | Di prim'ordine | |
| ROE (TTM) | -124.0%media 5 anni ≈-963.7% | ≈-963.7% | 19.1% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | HCA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | -6.5media 5 anni ≈-19.5 | ≈-19.5 | 0.2 | Basso indebitamento | |
| Rapporto corrente (MRQ) | 1.0media 5 anni ≈1.2 | ≈1.2 | 1.2 | Bassa liquidità | |
| Quick Ratio | 0.7media 5 anni ≈0.9 | ≈0.9 | 0.9 | Bassa liquidità | |
| Debito a lungo termine / Patrimonio netto (MRQ) | -6.5media 5 anni ≈-18.7 | ≈-18.7 | 0.2 | Basso indebitamento |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | HCA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 7.1%media 5 anni ≈8.0% | ≈8.0% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 7.9%media 5 anni ≈7.4% | ≈7.4% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 8.0% | · | · | · | |
| EPS YoY | 28.8%media 5 anni ≈25.6% | ≈25.6% | · | · | |
| Net Income YoY (Utile Netto YoY) | 17.8%media 5 anni ≈17.4% | ≈17.4% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3 anni) | 13.9%media 5 anni ≈11.8% | ≈11.8% | · | · | |
| EPS CAGR 5Y (CAGR EPS 5 anni) | 21.0% | · | · | · | |
| Net Income CAGR 3Y (CAGR Utile Netto 3 anni) | 6.3%media 5 anni ≈4.0% | ≈4.0% | · | · | |
| Net Income CAGR 5Y (CAGR Utile Netto 5 anni) | 12.6% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | HCA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 1.3media 5 anni ≈1.2 | ≈1.2 | 0.8 | Di prim'ordine | |
| Receivables Turnover (Rotazione dei crediti) | 7.0media 5 anni ≈7.1 | ≈7.1 | 8.4 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$328.7K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
| Data ex-dividendo | Importo | Valuta | Rendimento |
|---|---|---|---|
| Set 16, 2026 | $0,78 | USD | ≈0.71% |
| Giu 16, 2026 | $0,78 | USD | ≈0.76% |
| Mar 17, 2026 | $0,78 | USD | ≈0.58% |
| Dic 15, 2025 | $0,72 | USD | ≈0.60% |
| Set 16, 2025 | $0,72 | USD | ≈0.71% |
| Giu 16, 2025 | $0,72 | USD | ≈0.75% |
| Mar 17, 2025 | $0,72 | USD | ≈0.82% |
| Dic 13, 2024 | $0,66 | USD | ≈0.84% |
| Set 16, 2024 | $0,66 | USD | ≈0.64% |
| Giu 14, 2024 | $0,66 | USD | ≈0.75% |
| Mar 14, 2024 | $0,66 | USD | ≈0.76% |
| Dic 13, 2023 | $0,60 | USD | ≈0.89% |
| Set 14, 2023 | $0,60 | USD | ≈0.90% |
| Giu 15, 2023 | $0,60 | USD | ≈0.81% |
| Mar 16, 2023 | $0,60 | USD | ≈0.90% |
| Dic 13, 2022 | $0,56 | USD | ≈0.92% |
| Set 15, 2022 | $0,56 | USD | ≈1.0% |
| Giu 15, 2022 | $0,56 | USD | ≈1.1% |
| Mar 16, 2022 | $0,56 | USD | ≈0.75% |
| Dic 13, 2021 | $0,48 | USD | ≈0.90% |
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Lug 23, 2026 | $7.62 | $7.54 | 1.0% |
| 31 Marzo 2026 | $7.15 | $7.21 | -0.85% | |
| 31 Dicembre 2025 | $8.14 | $7.53 | 8.0% | |
| 30 Settembre 2025 | $6.96 | $5.77 | 20.6% | |
| 30 Giugno 2025 | $6.83 | $6.31 | 8.2% | |
| 31 Marzo 2025 | $6.45 | $5.84 | 10.5% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| SG&A Expense | $548M | $421M | $353M | $307M | $337M | $416M | $370M | $344M | $340M | $343M | |
| Operating Expenses | $65.77B | $62.08B | $57.26B | $51.65B | $48.92B | $46.10B | $46.09B | $41.34B | $39.23B | $36.68B | |
| Interest Expense | $2.25B | $2.06B | $1.94B | $1.74B | $1.57B | $1.58B | $1.82B | $1.75B | $1.69B | $1.71B | |
| Pretax Income | $9.83B | $8.52B | $7.71B | $8.58B | $9.83B | $5.43B | $5.24B | $5.33B | $4.38B | $4.81B | |
| Income Tax | $2.05B | $1.87B | $1.61B | $1.75B | $2.11B | $1.04B | $1.10B | $946M | $1.64B | $1.38B | |
| Net Income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| EPS (Basic) | $28.70 | $22.27 | $19.25 | $19.43 | $21.52 | $11.10 | $10.27 | $10.90 | $6.12 | $7.53 | |
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 | |
| Shares (Basic) | 236,413,000 | 258,603,000 | 272,404,000 | 290,348,000 | 323,315,000 | 338,274,000 | 341,210,000 | 347,297,000 | 362,305,000 | 383,591,000 | |
| Shares (Diluted) | 239,495,000 | 261,806,000 | 276,412,000 | 294,666,000 | 328,752,000 | 343,605,000 | 348,226,000 | 355,303,000 | 372,221,000 | 395,851,000 | |
| EBITDA | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.04B | $1.93B | $935M | $908M | $1.45B | $1.79B | $621M | $502M | $732M | $646M | |
| Short-term Investments | · | · | · | · | · | $116M | $147M | $47M | $54M | $49M | |
| Receivables | $10.87B | $10.75B | $9.96B | $8.89B | $8.10B | $7.05B | $7.38B | $6.79B | $6.50B | $5.83B | |
| Inventory | $1.65B | $1.74B | $2.02B | $2.07B | $1.99B | $2.02B | $1.85B | $1.73B | $1.57B | $1.50B | |
| Other Current Assets | $2.22B | $1.99B | $2.01B | $1.78B | $2.01B | $1.46B | $1.35B | $1.19B | $1.17B | $1.11B | |
| Current Assets | $15.78B | $16.41B | $14.93B | $13.64B | $13.54B | $12.33B | $11.20B | $10.21B | $9.98B | $9.09B | |
| PP&E (Net) | $31.14B | $29.41B | $27.71B | $25.57B | $24.06B | $23.20B | $22.71B | $19.76B | $17.89B | $16.35B | |
| PP&E (Gross) | $66.28B | $62.51B | $58.55B | $54.76B | $51.35B | $49.32B | $47.23B | $42.97B | $40.08B | $37.05B | |
| Accum. Depreciation | $35.13B | $33.10B | $30.83B | $29.18B | $27.29B | $26.12B | $24.52B | $23.21B | $22.19B | $20.70B | |
| Other Non-current Assets | $255M | $230M | $184M | $298M | $598M | $546M | $480M | $690M | $710M | $1.07B | |
| Total Assets | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Accounts Payable | $4.66B | $4.28B | $4.23B | $4.24B | $4.11B | $3.54B | $2.90B | $2.58B | $2.61B | $2.32B | |
| Current Liabilities | $16.35B | $15.18B | $12.65B | $9.90B | $9.58B | $8.70B | $7.76B | $7.57B | $6.16B | $5.83B | |
| Capital Leases | $1.85B | $1.86B | $1.90B | $1.75B | $1.75B | $1.67B | $1.50B | · | · | · | |
| Total Liabilities | · | · | · | · | · | · | $45.62B | $42.12B | $41.59B | $39.39B | |
| Long-term Debt | $44.28B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Total Debt | $41.60B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Retained Earnings | $-5.72B | $-2.12B | $-1.35B | $-2.28B | $-532M | $777M | $-2.35B | $-4.57B | $-6.53B | $-6.97B | |
| AOCI | $-305M | $-387M | $-425M | $-490M | $-404M | $-502M | $-460M | $-381M | $-278M | $-338M | |
| Stockholders' Equity | $-6.03B | $-2.50B | $-1.77B | $-2.77B | $-933M | $572M | $-2.81B | $-4.95B | $-6.81B | $-7.30B | |
| Liabilities + Equity | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Shares Outstanding | 224,605,100 | 249,981,400 | 265,537,300 | 277,378,300 | 305,476,800 | 339,425,600 | 338,445,600 | 342,895,200 | 350,091,600 | 370,535,900 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B | |
| Stock-based Comp | $401M | $360M | $262M | $341M | $440M | $362M | $347M | $268M | $270M | $251M | |
| Amort. of Intangibles | $12M | $16M | $20M | $44M | $25M | $26M | · | · | · | · | |
| Other Non-cash | $1.93B | $1.08B | $850M | $-431M | $-1.29B | $2.40B | $1.07B | $461M | $-3.53B | $-2.67B | |
| Operating Cash Flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B | $9.23B | $7.60B | $6.76B | $5.43B | $5.65B | |
| CapEx | $4.94B | $4.88B | $4.74B | $4.39B | $3.58B | $2.83B | $4.16B | $3.57B | $3.02B | $2.76B | |
| Investing Cash Flow | $-4.99B | $-4.93B | $-5.32B | $-3.39B | $-2.64B | $-3.39B | $-5.72B | $-3.90B | $-4.28B | $-3.24B | |
| Debt Issued | $8.47B | $7.50B | $3.22B | $6.00B | $4.34B | $2.70B | $6.45B | $2.00B | $1.50B | $5.40B | |
| Net Debt Issued | $1.08B | $5.08B | $2.31B | $3.17B | $475M | $-737M | $1.13B | $296M | $749M | $925M | |
| Stock Repurchased | $10.07B | $6.04B | $3.81B | $7.00B | $8.21B | $441M | $1.03B | $1.53B | $2.05B | $2.75B | |
| Net Stock Activity | $-10.07B | $-6.04B | $-3.81B | $-7.00B | $-8.21B | $-441M | $-1.03B | $-1.53B | $-2.05B | $-2.75B | |
| Dividends Paid | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · | |
| Financing Cash Flow | $-8.55B | $-4.58B | $-4.09B | $-5.66B | $-6.66B | $-4.68B | $-1.77B | $-3.08B | $-1.06B | $-2.51B | |
| Net Change in Cash | $-893M | $998M | $27M | $-543M | $-342M | $1.17B | $119M | $-230M | $86M | $-95M | |
| Taxes Paid | $1.74B | $1.84B | $1.39B | $1.18B | $2.18B | $1.00B | $849M | $872M | $1.21B | $1.25B | |
| Free Cash Flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B | $6.40B | $3.44B | $3.19B | $2.41B | $2.89B | |
| Levered FCF | $5.91B | $4.03B | $3.16B | $2.74B | $4.15B | $5.12B | $2.00B | $1.74B | $1.35B | $1.68B |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | 7.3% | 6.8% | 8.1% | · | · | |
| Pretax Margin | 13.0% | 12.1% | 11.9% | 14.2% | 16.7% | 10.5% | 10.2% | 11.4% | · | · | |
| EBITDA Margin | 4.7% | 4.7% | 4.7% | 4.9% | 4.9% | 5.3% | 5.1% | 4.9% | · | · | |
| ROA | 11.3% | 10.0% | 9.7% | 10.9% | 14.2% | 8.1% | 8.3% | 10.0% | 6.3% | 8.7% | |
| ROE | -159.1% | -269.6% | -230.9% | -305.0% | -3853.7% | -335.8% | -90.4% | -64.4% | -31.4% | -38.8% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.6 | 1.6 | |
| Quick Ratio | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.0 | 1.2 | 1.1 | |
| Debt / Equity | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 | 54.2 | -12.0 | -6.6 | -4.9 | -4.3 | |
| LT Debt / Equity | -6.9 | -15.3 | -21.0 | -13.6 | -36.8 | 53.8 | -12.0 | -6.5 | -4.8 | -4.3 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | · | · | |
| Receivables Turnover | 7.0 | 6.8 | 6.9 | 7.1 | 7.8 | 7.1 | 7.2 | 7.0 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-26.83 | $-10.00 | $-6.68 | $-9.98 | $-3.05 | $1.69 | $-8.30 | $-14.44 | $-19.44 | $-19.71 | |
| Revenue / Share | $315.66 | $269.68 | $235.04 | $204.41 | $178.71 | $149.98 | $147.42 | $131.37 | · | · | |
| Cash Flow / Share | $52.76 | $40.16 | $34.12 | $28.92 | $27.25 | $26.87 | $21.83 | $19.03 | $14.58 | $14.28 | |
| Cash / Share | $4.63 | $7.73 | $3.52 | $3.27 | $4.75 | $5.28 | $1.83 | $1.46 | $2.09 | $1.74 | |
| Dividend / Share | $2.88 | $2.64 | $2.40 | $2.24 | $1.92 | $0.43 | $1.60 | $1.40 | · | · | |
| EPS (TTM) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.1% | 8.7% | 7.9% | 2.5% | 14.0% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.9% | 6.3% | 8.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.0% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 28.8% | 16.0% | -0.94% | -9.5% | 93.6% | · | · | · | · | · | |
| EPS CAGR 3Y | 13.9% | 1.3% | 20.2% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 21.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 17.8% | 9.9% | -7.1% | -18.9% | 85.3% | · | · | · | · | · | |
| Net Income CAGR 3Y | 6.3% | -6.1% | 11.8% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 34.7% | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| Net Income TTM | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| Market Cap | $104.86B | $75.03B | $71.88B | $66.56B | $78.48B | $55.82B | $50.03B | $42.67B | $30.75B | $27.43B | |
| Enterprise Value | $145.42B | $116.13B | $110.53B | $103.74B | $111.61B | $84.92B | $82.98B | $74.95B | $63.02B | $58.11B | |
| P/E | 16.5 | 13.6 | 14.3 | 12.5 | 12.1 | 15.0 | 14.7 | 11.7 | 14.8 | 10.1 | |
| P/S | 1.4 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.0 | 0.9 | 0.7 | 0.7 | |
| P/B | -17.4 | -30.0 | -40.5 | -24.1 | -84.1 | 97.6 | -17.8 | -8.6 | -4.5 | -3.8 | |
| P / Tangible Book | · | · | · | · | · | 97.6 | · | · | · | · | |
| P / Cash Flow | 8.3 | 7.1 | 7.6 | 7.8 | 8.8 | 6.0 | 6.6 | 6.3 | 5.7 | 4.9 | |
| P / FCF | 13.6 | 13.3 | 15.3 | 16.1 | 14.6 | 8.7 | 14.5 | 13.4 | 12.8 | 9.5 | |
| EV / EBITDA | 41.3 | 35.1 | 35.9 | 34.9 | 39.1 | 31.2 | 32.0 | 32.9 | 29.6 | 29.6 | |
| EV / FCF | 18.9 | 20.6 | 23.6 | 25.1 | 20.7 | 13.3 | 24.1 | 23.5 | 26.1 | 20.1 | |
| EV / Revenue | 1.9 | 1.6 | 1.7 | 1.7 | 1.9 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | |
| Dividend Yield | 0.65% | 0.92% | 0.92% | 0.98% | 0.80% | 0.27% | 1.1% | 1.1% | 0.00% | · | |
| Earnings Yield | 6.1% | 7.3% | 7.0% | 8.0% | 8.2% | 6.7% | 6.8% | 8.6% | 6.8% | 9.9% | |
| Payout Ratio | 10.0% | 12.0% | 12.6% | 11.6% | 9.0% | 4.1% | 15.7% | 12.9% | · | · | |
| Annual Payout | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B | $17.49B | $17.34B | $17.30B | $16.21B | $15.86B | $15.59B | $15.50B | $14.97B | |
| SG&A Expense | $148M | $133M | $153M | $139M | $130M | $126M | $120M | $111M | $100M | $90M | $108M | $89M | $82M | $74M | $79M | $74M | |
| Operating Expenses | $17.74B | $16.82B | $16.84B | $16.74B | $16.19B | $15.99B | $16.15B | $15.58B | $15.26B | $15.09B | $14.96B | $14.58B | $14.05B | $13.67B | $12.20B | $13.27B | |
| Interest Expense | $599M | $584M | $572M | $561M | $568M | $547M | $528M | $515M | $506M | $512M | $491M | $483M | $485M | $479M | $453M | $446M | |
| Pretax Income | $2.49B | $2.29B | $2.67B | $2.42B | $2.42B | $2.33B | $2.13B | $1.91B | $2.24B | $2.25B | $2.35B | $1.63B | $1.81B | $1.92B | $3.30B | $1.70B | |
| Income Tax | $564M | $430M | $509M | $515M | $524M | $502M | $447M | $424M | $550M | $445M | $484M | $355M | $397M | $379M | $656M | $360M | |
| Net Income | $1.70B | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B | $1.27B | $1.46B | $1.59B | $1.61B | $1.08B | $1.19B | $1.36B | $2.08B | $1.13B | |
| EPS (Basic) | $7.70 | $7.25 | $8.22 | $7.05 | $6.91 | $6.52 | $5.72 | $4.94 | $5.60 | $6.01 | $6.00 | $3.98 | $4.35 | $4.92 | $7.30 | $3.97 | |
| EPS (Diluted) | $7.62 | $7.15 | $8.09 | $6.96 | $6.83 | $6.45 | $5.66 | $4.88 | $5.53 | $5.93 | $5.92 | $3.91 | $4.29 | $4.85 | $7.20 | $3.91 | |
| Shares (Basic) | 220,538,000 | 223,588,000 | · | 232,891,000 | 239,173,000 | 246,936,000 | · | 256,763,000 | 261,156,000 | 264,435,000 | · | 271,173,000 | 274,494,000 | 276,910,000 | · | 285,958,000 | |
| Shares (Diluted) | 222,828,000 | 226,652,000 | · | 236,181,000 | 241,911,000 | 249,440,000 | · | 259,917,000 | 264,071,000 | 268,016,000 | · | 275,424,000 | 278,198,000 | 280,961,000 | · | 289,852,000 | |
| EBITDA | $944M | $930M | · | $889M | $863M | $860M | · | $842M | $819M | $795M | · | $769M | $763M | $756M | · | $749M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.01B | $940M | $1.04B | $997M | $939M | $1.06B | $1.93B | $2.89B | $831M | $1.28B | · | $891M | $862M | $842M | · | $999M | |
| Receivables | $12.28B | $11.32B | $10.87B | $10.43B | $10.46B | $11.09B | $10.75B | $9.91B | $10.24B | $10.04B | · | $9.18B | $8.71B | $8.66B | · | $8.55B | |
| Inventory | $1.66B | $1.68B | $1.65B | $1.73B | $1.79B | $1.79B | $1.74B | $1.78B | $1.80B | $1.90B | · | $2.03B | $2.05B | $2.08B | · | $2.01B | |
| Other Current Assets | $2.23B | $2.11B | $2.22B | $2.13B | $2.37B | $2.32B | $1.99B | $2.08B | $2.30B | $2.05B | · | $2.19B | $2.26B | $1.96B | · | $1.92B | |
| Current Assets | $17.19B | $16.05B | $15.78B | $15.29B | $15.56B | $16.26B | $16.41B | $16.66B | $15.17B | $15.28B | · | $14.29B | $13.89B | $13.54B | · | $13.48B | |
| PP&E (Net) | $31.82B | $31.47B | $31.14B | $30.57B | $30.12B | $29.74B | $29.41B | $29.05B | $28.64B | $28.10B | · | $27.12B | $26.64B | $26.05B | · | $24.98B | |
| PP&E (Gross) | $68.41B | $67.36B | $66.28B | $65.49B | $64.39B | $63.68B | $62.51B | $61.75B | $60.62B | $59.44B | · | $57.77B | $56.67B | $55.46B | · | $53.73B | |
| Accum. Depreciation | $36.59B | $35.89B | $35.13B | $34.92B | $34.27B | $33.94B | $33.10B | $32.70B | $31.99B | $31.34B | · | $30.66B | $30.02B | $29.41B | · | $28.75B | |
| Other Non-current Assets | $258M | $326M | $255M | $277M | $236M | $226M | $230M | $309M | $240M | $199M | · | $200M | $196M | $319M | · | $461M | |
| Total Assets | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | $56.21B | $54.59B | $53.59B | $52.71B | $52.44B | $51.48B | |
| Accounts Payable | $4.75B | $4.81B | $4.66B | $4.55B | $4.25B | $4.49B | $4.28B | $4.24B | $4.03B | $4.74B | · | $4.14B | $3.82B | $3.77B | · | $4.16B | |
| Current Liabilities | $17.31B | $19.26B | $16.35B | $17.90B | $15.94B | $13.63B | $15.18B | $14.90B | $14.30B | $13.14B | · | $12.41B | $11.54B | $11.03B | · | $9.78B | |
| Capital Leases | $1.83B | $1.82B | $1.85B | $1.84B | $1.88B | $1.86B | $1.86B | $1.92B | $1.89B | $1.91B | · | $1.78B | $1.81B | $1.72B | · | $1.76B | |
| Long-term Debt | $45.83B | $44.37B | $44.28B | $42.60B | $42.70B | $44.58B | $43.03B | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Total Debt | $43.45B | $39.49B | · | $38.40B | $39.38B | $44.58B | · | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Retained Earnings | $-6.31B | $-5.98B | $-5.72B | $-5.02B | $-4.09B | $-3.16B | $-2.12B | $-1.81B | $-1.17B | $-1.19B | · | $-1.99B | $-1.85B | $-2.03B | · | $-2.78B | |
| AOCI | $-334M | $-327M | $-305M | $-317M | $-309M | $-357M | $-387M | $-378M | $-433M | $-433M | $-425M | $-491M | $-456M | $-470M | $-490M | $-592M | |
| Stockholders' Equity | $-6.64B | $-6.30B | $-6.03B | $-5.33B | $-4.39B | $-3.52B | $-2.50B | $-2.18B | $-1.60B | $-1.61B | · | $-2.48B | $-2.30B | $-2.50B | · | $-3.37B | |
| Liabilities + Equity | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | · | $54.59B | $53.59B | $52.71B | · | $51.48B | |
| Shares Outstanding | 217,963,300 | 222,530,900 | 224,605,100 | 229,845,100 | 236,143,900 | 242,955,400 | 249,981,400 | 254,517,700 | 259,237,600 | 263,215,800 | · | 268,967,300 | 272,931,700 | 275,939,900 | · | 283,903,500 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $944M | $930M | $911M | $889M | $863M | $860M | $856M | $842M | $819M | $795M | $789M | $769M | $763M | $756M | $750M | $749M | |
| Stock-based Comp | $85M | $86M | $100M | $104M | $99M | $98M | $85M | $76M | $112M | $87M | $57M | $72M | $56M | $77M | $83M | $87M | |
| Other Non-cash | · | $-622M | · | · | · | $-917M | · | · | · | $-4M | · | · | · | $-393M | · | · | |
| Operating Cash Flow | $2.33B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B | $3.52B | $1.97B | $2.47B | $2.67B | $2.48B | $2.48B | $1.80B | $2.53B | $3.02B | |
| CapEx | $1.23B | $1.12B | $1.49B | $1.29B | $1.18B | $991M | $1.28B | $1.19B | $1.28B | $1.12B | $1.16B | $1.15B | $1.24B | $1.20B | $1.32B | $1.13B | |
| Investing Cash Flow | $-1.56B | $-1.28B | $-1.32B | $-1.39B | $-1.25B | $-1.03B | $-1.35B | $-1.35B | $-1.33B | $-903M | $-1.60B | $-1.31B | $-1.26B | $-1.15B | $-793M | $-546M | |
| Debt Issued | $2.99B | $0 | $3.24B | $0 | $0 | $5.23B | $0 | $3.01B | $0 | $4.48B | $4M | $2M | $3.22B | $0 | $21M | $10M | |
| Net Debt Issued | · | $-58M | · | · | · | $1.34B | · | · | · | $2.42B | · | · | · | $-550M | · | · | |
| Stock Repurchased | $2.06B | $1.57B | $2.56B | $2.50B | $2.50B | $2.51B | $1.70B | $1.79B | $1.37B | $1.18B | $910M | $1.14B | $915M | $846M | $1.52B | $698M | |
| Net Stock Activity | · | $-1.57B | · | · | · | $-2.51B | · | · | · | $-1.18B | · | · | · | $-846M | · | · | |
| Dividends Paid | $171M | $183M | $162M | $166M | $171M | $180M | $165M | $169M | $171M | $185M | $160M | $162M | $164M | $175M | $156M | $160M | |
| Financing Cash Flow | $-704M | $-830M | $-999M | $-2.97B | $-3.09B | $-1.50B | $-2.16B | $-110M | $-1.09B | $-1.22B | $-1.04B | $-1.13B | $-1.20B | $-725M | $-1.84B | $-2.32B | |
| Net Change in Cash | $73M | $-100M | $43M | $58M | $-121M | $-873M | $-955M | $2.06B | $-453M | $349M | $44M | $29M | $20M | $-66M | $-91M | $141M | |
| Taxes Paid | $730M | $-5M | $1.51B | $81M | $136M | $10M | $358M | $487M | $998M | $1M | $316M | $297M | $766M | $7M | $244M | $322M | |
| Free Cash Flow | · | $895M | · | · | · | $660M | · | · | · | $1.35B | · | · | · | $606M | · | · | |
| Levered FCF | · | $421M | · | · | · | $231M | · | · | · | $940M | · | · | · | $221M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 8.4% | 8.5% | · | 8.6% | 8.9% | 8.8% | · | 7.3% | 8.3% | 9.2% | · | 6.7% | 7.5% | 8.7% | · | 7.6% | |
| Pretax Margin | 12.3% | 12.0% | · | 12.6% | 13.0% | 12.7% | · | 10.9% | 12.8% | 13.0% | · | 10.1% | 11.4% | 12.3% | · | 11.4% | |
| EBITDA Margin | 4.7% | 4.9% | · | 4.6% | 4.6% | 4.7% | · | 4.8% | 4.7% | 4.6% | · | 4.7% | 4.8% | 4.9% | · | 5.0% | |
| ROA | 2.8% | 2.7% | · | 2.8% | 2.8% | 2.8% | · | 2.2% | 2.6% | 2.9% | · | 2.0% | 2.3% | 2.6% | · | 2.2% | |
| ROE | -30.8% | -33.0% | · | -43.7% | -55.2% | -62.7% | · | -54.5% | -74.9% | -77.4% | · | -36.9% | -39.9% | -60.2% | · | -55.8% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.8 | · | 0.9 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 0.8 | 0.6 | · | 0.6 | 0.7 | 0.9 | · | 0.9 | 0.8 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 1.0 | |
| Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -12.7 | · | -19.7 | -25.6 | -24.9 | · | -15.9 | -16.9 | -15.6 | · | -11.2 | |
| LT Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -11.7 | · | -17.5 | -22.7 | -23.0 | · | -14.9 | -15.9 | -14.6 | · | -11.1 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.8 | 1.7 | · | 1.8 | 1.8 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-30.47 | $-28.32 | · | $-23.21 | $-18.61 | $-14.48 | · | $-8.57 | $-6.17 | $-6.14 | · | $-9.21 | $-8.44 | $-9.04 | · | $-11.87 | |
| Revenue / Share | $90.79 | $84.31 | · | $81.13 | $76.91 | $73.45 | · | $67.28 | $66.24 | $64.69 | · | $58.87 | $57.01 | $55.49 | · | $51.65 | |
| Cash Flow / Share | · | $8.89 | · | · | · | $6.62 | · | · | · | $9.21 | · | · | · | $6.42 | · | · | |
| Cash / Share | $4.65 | $4.22 | · | $4.34 | $3.98 | $4.36 | · | $11.35 | $3.21 | $4.88 | · | $3.31 | $3.16 | $3.05 | · | $3.52 | |
| Dividend / Share | $0.78 | $0.78 | $0.72 | $0.72 | $0.72 | $0.72 | $0.66 | $0.66 | $0.66 | $0.66 | $0.60 | $0.60 | $0.60 | $0.60 | $0.56 | $0.56 | |
| EPS (TTM) | $29.82 | $29.03 | · | $25.90 | $23.82 | $22.52 | · | $22.26 | $21.29 | $20.05 | · | $20.25 | $20.25 | $19.86 | · | $17.61 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $78.01B | $76.39B | · | $74.37B | $72.70B | $71.58B | · | $69.62B | $68.35B | $66.72B | · | $63.16B | $61.92B | $60.88B | · | $59.80B | |
| Net Income TTM | $6.84B | $6.79B | · | $6.34B | $5.97B | $5.78B | · | $5.93B | $5.74B | $5.47B | · | $5.72B | $5.77B | $5.73B | · | $5.38B | |
| Market Cap | $84.98B | $105.31B | · | $97.96B | $90.47B | $83.95B | · | $103.44B | $83.29B | $87.79B | · | $66.16B | $82.83B | $72.76B | · | $52.18B | |
| Enterprise Value | $127.42B | $143.86B | · | $135.36B | $128.91B | $127.47B | · | $143.52B | $123.34B | $126.70B | · | $104.62B | $120.90B | $110.77B | · | $88.89B | |
| P/E | 13.1 | 16.3 | · | 16.5 | 16.1 | 15.3 | · | 18.3 | 15.1 | 16.6 | · | 12.1 | 15.0 | 13.3 | · | 10.4 | |
| P/S | 1.1 | 1.4 | · | 1.3 | 1.2 | 1.2 | · | 1.5 | 1.2 | 1.3 | · | 1.0 | 1.3 | 1.2 | · | 0.9 | |
| P/B | -12.8 | -16.7 | · | -18.4 | -20.6 | -23.9 | · | -47.4 | -52.1 | -54.4 | · | -26.7 | -36.0 | -29.2 | · | -15.5 | |
| P / Cash Flow | · | 52.3 | · | · | · | 50.8 | · | · | · | 35.6 | · | · | · | 40.4 | · | · | |
| EV / Revenue | 1.6 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.1 | 1.8 | 1.9 | · | 1.7 | 2.0 | 1.8 | · | 1.5 | |
| Dividend Yield | 0.80% | 0.65% | · | 0.70% | 0.76% | 0.82% | · | 0.66% | 0.81% | 0.76% | · | 0.99% | 0.79% | 0.89% | · | 1.2% | |
| Earnings Yield | 7.6% | 6.1% | · | 6.1% | 6.2% | 6.5% | · | 5.5% | 6.6% | 6.0% | · | 8.2% | 6.7% | 7.5% | · | 9.6% | |
| Payout Ratio | · | 11.3% | · | · | · | 11.2% | · | · | · | 11.6% | · | · | · | 12.8% | · | · | |
| Annual Payout | $682M | $682M | · | $682M | $685M | $685M | · | $685M | $678M | $671M | · | $657M | $655M | $651M | · | $645M |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B |
| Utile netto | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B |
| EPS Diluito | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 |
| Rapporto corrente | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 |
| Quick Ratio | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B |
Proprietari istituzionali (13F) 1.474 filer · $57.2B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 121 (-64 vs trimestre precedente) | 176 (+72 vs trimestre precedente) | 458 (-25 vs trimestre precedente) | 581 (+4 vs trimestre precedente) | -627K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6.870.392.526 | 14.716.173 | 12,00% | Azioni |
| BlackRock, Inc. | $5.069.973.824 | 13.003.600 | 8,86% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.954.150.533 | 10.141.708 | 6,91% | Azioni |
| Sanders Capital, LLC | $3.442.060.818 | 8.828.287 | 6,01% | Azioni |
| STATE STREET CORP | $2.912.102.056 | 7.469.035 | 5,09% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $1.835.396.649 | 4.707.473 | 3,21% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $1.423.654.808 | 3.668.008 | 2,49% | Azioni |
| First Eagle Investment Management, LLC | $1.284.907.912 | 3.295.565 | 2,24% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.057.704.509 | 2.712.828 | 1,85% | Azioni |
| MORGAN STANLEY | $1.008.556.857 | 2.586.771 | 1,76% | Azioni |
| GOLDMAN SACHS GROUP INC | $960.811.481 | 2.464.314 | 1,68% | Azioni |
| JPMORGAN CHASE & CO | $896.800.955 | 2.285.832 | 1,57% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $861.456.107 | 2.209.485 | 1,50% | Azioni |
| NORGES BANK | $836.457.140 | 2.145.367 | 1,46% | Azioni |
| Capital World Investors | $770.864.224 | 1.977.121 | 1,35% | Azioni |
| Capital International Investors | $747.403.041 | 1.916.947 | 1,31% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $709.859.997 | 1.500.000 | 1,24% | Azioni |
| NORTHERN TRUST CORP | $666.150.458 | 1.708.560 | 1,16% | Azioni |
| FMR LLC | $636.503.475 | 1.632.520 | 1,11% | Azioni |
| Invesco Ltd. | $596.390.232 | 1.529.637 | 1,04% | Azioni |
| NORDEA INVESTMENT MANAGEMENT AB | $553.702.529 | 1.429.943 | 0,97% | Azioni |
| BARCLAYS PLC | $514.349.127 | 1.319.216 | 0,90% | Azioni |
| JANUS HENDERSON GROUP PLC | $481.486.890 | 1.017.441 | 0,84% | Azioni |
| Crake Asset Management LLP | $449.072.183 | 1.151.792 | 0,78% | Azioni |
| Metropolis Capital Ltd | $430.915.307 | 910.564 | 0,75% | Azioni |
| Darsana Capital Partners LP | $428.879.000 | 1.100.000 | 0,75% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $414.565.358 | 1.063.288 | 0,72% | Azioni |
| Legal & General Group Plc | $410.992.402 | 1.054.124 | 0,72% | Azioni |
| FRANKLIN RESOURCES INC | $399.958.688 | 1.025.824 | 0,70% | Azioni |
| Life Cycle Investment Partners Ltd | $355.737.196 | 912.404 | 0,62% | Azioni |
| Bank of New York Mellon Corp | $350.359.895 | 898.612 | 0,61% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $339.685.814 | 871.235 | 0,59% | Azioni |
| ROYAL BANK OF CANADA | $320.194.000 | 821.241 | 0,56% | Azioni |
| LYRICAL ASSET MANAGEMENT LP | $255.015.742 | 654.071 | 0,45% | Azioni |
| BANK OF AMERICA CORP /DE/ | $238.456.934 | 611.601 | 0,42% | Azioni |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $237.236.367 | 608.470 | 0,41% | Azioni |
| ROYAL LONDON ASSET MANAGEMENT LTD | $235.649.908 | 604.401 | 0,41% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $234.827.401 | 602.290 | 0,41% | Azioni |
| UBS Group AG | $230.953.291 | 592.355 | 0,40% | Azioni |
| National Pension Service | $230.650.346 | 591.578 | 0,40% | Azioni |
| Russell Investments Group, Ltd. | $206.832.565 | 530.340 | 0,36% | Azioni |
| Nuveen, LLC | $199.595.109 | 511.927 | 0,35% | Azioni |
| Gobi Capital LLC | $195.742.325 | 502.045 | 0,34% | Azioni |
| Cryder Capital Partners LLP | $194.561.738 | 499.017 | 0,34% | Azioni |
| Allianz Asset Management GmbH | $181.127.299 | 464.560 | 0,32% | Azioni |
| DEUTSCHE BANK AG\ | $175.985.429 | 451.372 | 0,31% | Azioni |
| Swiss National Bank | $172.097.446 | 441.400 | 0,30% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $172.079.393 | 441.313 | 0,30% | Azioni |
| AustralianSuper Pty Ltd | $159.635.782 | 409.438 | 0,28% | Azioni |
| HSBC HOLDINGS PLC | $158.555.065 | 406.750 | 0,28% | Azioni |
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan | 10 Febbraio 2026 | 31,60% | Deposito iniziale | · | SEC |
| 22 Novembre 2006 | · | Deposito iniziale | · | SEC | |
| Merrill Lynch Bank USA | 11 Settembre 2006 | · | Deposito iniziale | · | SEC |
| Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC | 04 Agosto 2006 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 92 insider · 54 dirigenti · 31 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Samuel N Hazen | CEO | 10 Febbraio 2026 F | 64.842 | 0 | 7 | $-21.483.290 |
| O'Boyle Michael P | President & CEO - Parallon | 26 Febbraio 2013 A | 21.429 | 0 | 0 | $0 |
| Mike A Marks | EVP and CFO | 07 Maggio 2026 G | 46.576 | 0 | 0 | $0 |
| Bill B Rutherford | CFO and EVP | 16 Febbraio 2024 F | 22.251 | 0 | 0 | $0 |
| Russell K Harms | CFO - Central Group | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Robert Samuel Hankins JR | CFO-Outpatient Services Group | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Richard J Shallcross | CFO - Western Group | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Jeffrey T Crudele | CFO-Eastern Division | 01 Luglio 2005 F | 13.865 | 0 | 0 | $0 |
| Erol R Akdamar | Group President | 12 Novembre 2024 M | 6.843 | 0 | 0 | $0 |
| Timothy M Mcmanus | Group President | 31 Luglio 2024 M | 27.008 | 0 | 0 | $0 |
| Richard A Hammett | Group President | 16 Febbraio 2024 F | 17.936 | 0 | 0 | $0 |
| Charles J Hall | Group President | 11 Novembre 2022 M | 202.443 | 0 | 0 | $0 |
| Bruce A Moore JR | Group President - Service Line | 11 Novembre 2022 S | 30.807 | 0 | 0 | $0 |
| Paul W Rutledge | Group President | 31 Dicembre 2012 A | 335.657 | 0 | 0 | $0 |
| Beverly B Wallace | President - Parallon | 02 Novembre 2011 M | 144.714 | 0 | 0 | $0 |
| Charles Robert Evans | President - Eastern Group | 26 Luglio 2006 A | 62.173 | 0 | 0 | $0 |
| Marilyn B Tavenner | President-Outpatient Svcs Grp | 27 Ottobre 2005 A | 26.154 | 0 | 0 | $0 |
| Greg Roth | President-Ambulatory Surgery | 31 Ottobre 2004 D | 9.029 | 0 | 0 | $0 |
| Jay Grinney | President-Eastern Group | 07 Maggio 2004 D | 24.177 | 0 | 0 | $0 |
| Jon M Foster | EVP and COO | 10 Febbraio 2026 F | 23.062 | 0 | 0 | $0 |
| Michael R Mcalevey | EVP & Chief Legal & Admin Off. | 26 Agosto 2026 J | 0 | 0 | 2 | $-2.747.520 |
| Jennifer Berres | SVP & Chief Human Res. Officer | 11 Febbraio 2026 S | 11.993 | 0 | 2 | $-4.126.932 |
| Christopher F. Wyatt | SVP & Controller | 11 Febbraio 2026 S | 44.379 | 0 | 1 | $-2.020.000 |
| Erica Rossitto | SVP & Chief Nurse Executive | 10 Febbraio 2026 F | 10.407 | 0 | 0 | $0 |
| Michael S. Cuffe | EVP and Chief Clinical Officer | 10 Febbraio 2026 F | 32.080 | 0 | 1 | $-747.135 |
| Sammie S Mosier | SVP & Chief Nurse Executive | 13 Febbraio 2025 F | 11.113 | 0 | 0 | $0 |
| Kathleen M Whalen | SVP & Chief Ethics Officer | 14 Novembre 2024 S | 9.454 | 0 | 0 | $0 |
| Phillip G Billington | SVP-Internal Audit Services | 12 Novembre 2024 M | 52.702 | 0 | 0 | $0 |
| Joseph A Sowell III | SVP; Chief Development Officer | 05 Agosto 2024 G | 18.526 | 0 | 0 | $0 |
| Deborah M Reiner | SVP - Mktg. & Communications | 29 Luglio 2024 S | 3.510 | 0 | 0 | $0 |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 25 Luglio 2024 S | 17.755 | 0 | 0 | $0 |
| Jeffrey E. Cohen | SVP-Government Relations | 09 Maggio 2024 S | 5.185 | 0 | 0 | $0 |
| Chad J Wasserman | SVP and CIO | 18 Marzo 2024 M | 1.576 | 0 | 0 | $0 |
| Martin P. Paslick | SVP and CIO | 12 Aprile 2023 M | 24.643 | 0 | 0 | $0 |
| Jane D. Englebright | SVP and Chief Nursing Officer | 09 Novembre 2021 S | 0 | 0 | 0 | $0 |
| Robert A Waterman | SVP & General Counsel | 05 Maggio 2021 S | 50.062 | 0 | 0 | $0 |
| William J Morrow | SVP - Finance and Treasurer | 18 Febbraio 2021 F | 5.578 | 0 | 0 | $0 |
| Sandra L. Morgan | SVP-Provider Relations | 18 Febbraio 2021 F | 10.122 | 0 | 0 | $0 |
| Victor L Campbell | SVP-Government Affairs | 01 Maggio 2019 A | 194.145 | 0 | 0 | $0 |
| John M Steele | SVP & Chief Human Res. Officer | 25 Febbraio 2019 M | 84.157 | 0 | 0 | $0 |
| Milton R Johnson | Chairman | 25 Febbraio 2019 M | 881.823 | 0 | 0 | $0 |
| Ravi S. Chari | SVP-Clinical Excellence | 25 Febbraio 2018 M | 7.003 | 0 | 0 | $0 |
| Alan R Yuspeh | SVP & Chief Ethics Officer | 25 Febbraio 2018 M | 35.546 | 0 | 0 | $0 |
| Joseph N Steakley | SVP-Internal Audit Services | 25 Febbraio 2018 M | 65.199 | 0 | 0 | $0 |
| Jana Joustra Davis | SVP - Mktg. & Corp. Affairs | 23 Maggio 2017 M | 26.378 | 0 | 0 | $0 |
| David Gwin Anderson | SVP - Finance | 07 Novembre 2016 M | 110.167 | 0 | 0 | $0 |
| Donald W Stinnett | SVP & Controller | 25 Febbraio 2016 A | 51.965 | 0 | 0 | $0 |
| Noel B Williams | SVP and CIO | 16 Maggio 2012 M | 299.030 | 0 | 0 | $0 |
| Jack O Bovender JR | Chairman | 06 Ottobre 2009 A | 188.340 | 0 | 0 | $0 |
| Carl V George | SVP - Development | 27 Febbraio 2009 M | 13.092 | 0 | 0 | $0 |
| Patricia T Lindler | SVP - Government Programs | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Rosalyn S Elton | SVP-Operations Finance | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Frank M Houser MD | SVP-Quality & Medical Director | 26 Luglio 2006 A | 46.145 | 0 | 0 | $0 |
| James A Fitzgerald JR | SVP-Supply Chain Operations | 29 Gennaio 2006 F | 20.674 | 0 | 0 | $0 |
| Andrea B Smith | Direttore | 28 Aprile 2026 A | 4.666 | 0 | 0 | $0 |
| William R Frist | Direttore | 28 Aprile 2026 A | 13.740 | 0 | 0 | $0 |
| Wayne Joseph Riley | Direttore | 28 Aprile 2026 A | 15.029 | 0 | 0 | $0 |
| Hugh F Johnston | Direttore | 28 Aprile 2026 A | 4.475 | 0 | 0 | $0 |
| Thomas F Frist III | Direttore | 28 Aprile 2026 A | 15.858 | 0 | 0 | $0 |
| Michael W Michelson | Direttore | 28 Aprile 2026 A | 12.576 | 0 | 0 | $0 |
| Nancy Ann Deparle | Direttore | 28 Aprile 2026 A | 21.910 | 0 | 0 | $0 |
| John Chidsey | Direttore | 28 Aprile 2026 A | 1.305 | 0 | 0 | $0 |
| Robert J Dennis | Direttore | 29 Aprile 2025 A | 26.601 | 0 | 0 | $0 |
| Meg Crofton | Direttore | 29 Aprile 2024 A | 6.331 | 0 | 0 | $0 |
| Charles O Holliday JR | Direttore | 25 Aprile 2022 A | 18.955 | 0 | 0 | $0 |
| Geoffrey G Meyers | Direttore | 01 Maggio 2019 A | 39.153 | 0 | 0 | $0 |
| John W Rowe | Direttore | 01 Maggio 2019 A | 30.388 | 0 | 0 | $0 |
| Ann H Lamont | Direttore | 02 Maggio 2018 A | 17.661 | 0 | 0 | $0 |
| Jay O Light | Direttore | 03 Maggio 2017 A | 30.953 | 0 | 0 | $0 |
| Stephen G Pagliuca | Direttore | 05 Dicembre 2014 D | 7.612.921 | 0 | 0 | $0 |
| Christopher R Gordon | Direttore | 01 Novembre 2013 D | 30.003.156 | 0 | 0 | $0 |
| John Connaughton | Direttore | 01 Novembre 2013 D | 30.003.156 | 0 | 0 | $0 |
| John H Mcarthur | Direttore | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Kent C Nelson | Direttore | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Magdalena Averhoff MD | Direttore | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Glenda A Hatchett | Direttore | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Frederick W Gluck | Direttore | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Harold T Shapiro | Direttore | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Michael C Armstrong | Direttore | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Martin Feldstein | Direttore | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Michael T Long | Direttore | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| ROYAL FRANK S | Direttore | 17 Novembre 2006 D | 0 | 0 | 0 | $0 |
| Patricia F Elcan | Proprietario del 10% | 06 Febbraio 2026 J | 36.557.141 | 0 | 0 | $0 |
| Frisco Holding II | Proprietario del 10% | 06 Febbraio 2026 J | 36.557.141 | 0 | 0 | $0 |
| HERCULES HOLDING II, LLC | Proprietario del 10% | 06 Febbraio 2026 J | 32.282.889 | 0 | 0 | $0 |
| Thomas F Frist JR | Proprietario del 10% | 06 Febbraio 2026 J | 36.557.141 | 0 | 0 | $0 |
| Patricia C Frist | Proprietario del 10% | 20 Febbraio 2018 G | 0 | 0 | 0 | $0 |
| KKR PEI GP LTD | Proprietario del 10% | 01 Aprile 2014 J | 0 | 0 | 0 | $0 |
| Jonathan B Perlin | · | 02 Agosto 2021 S | 44.348 | 0 | 0 | $0 |
| Juan Vallarino | · | 09 Maggio 2016 M | 61.036 | 0 | 0 | $0 |
| Richard M Bracken | · | 31 Dicembre 2014 F | 82.499 | 0 | 0 | $0 |
| BANK OF AMERICA CORP /DE/ | · | 06 Novembre 2012 S | 2.652.364 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 141 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| BUL · Pacer Funds Trust | 5,07% | 16.545 NS | 31 Luglio 2026 | N-PORT |
| IHF · iShares Trust | 4,75% | 147.977 SH | 11 Settembre 2026 | Giornaliero |
| STNC · Hennessy Funds Trust | 3,17% | 7.315 NS | 31 Luglio 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 2,47% | 97.151 SH | 05 Ottobre 2026 | Giornaliero |
| COWZ · Pacer Funds Trust | 2,07% | 960.711 NS | 31 Luglio 2026 | N-PORT |
| WLTG · ETF Opportunities Trust | 2,06% | 3.942 NS | 31 Luglio 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,67% | 34.181 SH | 05 Ottobre 2026 | Giornaliero |
| RPG · Invesco Exchange-Traded Fund Trust | 1,27% | 58.310 SH | 05 Ottobre 2026 | Giornaliero |
| FLAG · Global X Funds | 1,14% | 48 NS | 31 Luglio 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 1,03% | 6.909 NS | 31 Luglio 2026 | N-PORT |
| IYH · iShares Trust | 1,01% | 87.417 SH | 11 Settembre 2026 | Giornaliero |
| SRHQ · Elevation Series Trust | 0,94% | 4.938 NS | 31 Luglio 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0,92% | 48.109.000 SH | 11 Settembre 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,91% | 74.445 NS | 31 Luglio 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,90% | 470.451 SH | 19 Agosto 2026 | Giornaliero |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,87% | 22.725 NS | 31 Luglio 2026 | N-PORT |
| DIVB · iShares Trust | 0,87% | 42.100 SH | 11 Settembre 2026 | Giornaliero |
| NFRA · FlexShares Trust | 0,84% | 62.628 NS | 31 Luglio 2026 | N-PORT |
| IXJ · iShares Trust | 0,83% | 81.708 SH | 11 Settembre 2026 | Giornaliero |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,80% | 2.483 SH | 05 Ottobre 2026 | Giornaliero |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,79% | 3.522 NS | 31 Luglio 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,78% | 23.458.000 | 05 Ottobre 2026 | Giornaliero |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,74% | 25.787.000 | 05 Ottobre 2026 | Giornaliero |
| CURE · Direxion Shares ETF Trust | 0,72% | 3.056 NS | 31 Luglio 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,67% | 12.075 SH | 19 Agosto 2026 | Giornaliero |
| LGDX · Tidal Trust III | 0,66% | 2.345 NS | 31 Luglio 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,55% | 11.876 SH | 19 Agosto 2026 | Giornaliero |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,50% | 22.854.000 | 05 Ottobre 2026 | Giornaliero |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,46% | 7.404 NS | 31 Luglio 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,43% | 964 NS | 31 Luglio 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,42% | 7.289 NS | 31 Luglio 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,40% | 92.347 SH | 05 Ottobre 2026 | Giornaliero |
| QLC · FlexShares Trust | 0,39% | 9.856 NS | 31 Luglio 2026 | N-PORT |
| XOEF · iShares Trust | 0,37% | 194 SH | 11 Settembre 2026 | Giornaliero |
| GSY · Invesco Actively Managed Exchange-T… | 0,36% | 14.000.000 | 05 Ottobre 2026 | Giornaliero |
| UPSD · ETF Series Solutions | 0,33% | 972 NS | 31 Luglio 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,33% | 9.324.000 | 05 Ottobre 2026 | Giornaliero |
| MGV · VANGUARD WORLD FUND | 0,29% | 97.604 SH | 19 Agosto 2026 | Giornaliero |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,28% | 390.000 | 02 Ottobre 2026 | Giornaliero |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,28% | 3.186 NS | 31 Luglio 2026 | N-PORT |
| USXF · iShares Trust | 0,26% | 9.226 SH | 11 Settembre 2026 | Giornaliero |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,26% | 5.813 SH | 05 Ottobre 2026 | Giornaliero |
| IWX · iShares Trust | 0,23% | 21.535 SH | 11 Settembre 2026 | Giornaliero |
| VTV · VANGUARD INDEX FUNDS | 0,23% | 1.475.731 SH | 19 Agosto 2026 | Giornaliero |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 14.235 NS | 31 Luglio 2026 | N-PORT |
| MPLY · Strategy Shares | 0,22% | 87 NS | 31 Luglio 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,21% | 9.589 SH | 11 Settembre 2026 | Giornaliero |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 461.214 SH | 05 Ottobre 2026 | Giornaliero |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,20% | 6.420 NS | 31 Luglio 2026 | N-PORT |
| SIZE · iShares Trust | 0,19% | 1.920 SH | 11 Settembre 2026 | Giornaliero |
| DYNF · BlackRock ETF Trust | 0,19% | 183.934 SH | 11 Settembre 2026 | Giornaliero |
| VMAX · Lattice Strategies Trust | 0,19% | 228 NS | 31 Luglio 2026 | N-PORT |
| DSI · iShares Trust | 0,19% | 23.734 SH | 11 Settembre 2026 | Giornaliero |
| ILCV · iShares Trust | 0,18% | 5.870 SH | 10 Settembre 2026 | Giornaliero |
| IVW · iShares Trust | 0,18% | 331.185 SH | 11 Settembre 2026 | Giornaliero |
| IUSG · iShares Trust | 0,17% | 136.713 SH | 11 Settembre 2026 | Giornaliero |
| VOOG · VANGUARD ADMIRAL FUNDS | 0,17% | 115.334 SH | 19 Agosto 2026 | Giornaliero |
| IWD · iShares Trust | 0,17% | 332.035 SH | 11 Settembre 2026 | Giornaliero |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,16% | 90.157 SH | 19 Agosto 2026 | Giornaliero |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,16% | 17.773 SH | 05 Ottobre 2026 | Giornaliero |
| USMV · iShares Trust | 0,16% | 89.855 SH | 11 Settembre 2026 | Giornaliero |
| ACWV · iShares, Inc. | 0,15% | 11.903 SH | 11 Settembre 2026 | Giornaliero |
| EGLE · Global X Funds | 0,15% | 8 NS | 31 Luglio 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,15% | 4 NS | 31 Luglio 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,14% | 33.331 SH | 05 Ottobre 2026 | Giornaliero |
| VOXP · Advisors Series Trust | 0,13% | 18 NS | 31 Luglio 2026 | N-PORT |
| VRIG · Invesco Actively Managed Exchange-T… | 0,12% | 2.250.000 | 01 Ottobre 2026 | Giornaliero |
| TOPC · iShares Trust | 0,12% | 95 SH | 11 Settembre 2026 | Giornaliero |
| DGRO · iShares Trust | 0,12% | 120.741 SH | 11 Settembre 2026 | Giornaliero |
| XVV · iShares Trust | 0,11% | 1.790 SH | 11 Settembre 2026 | Giornaliero |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,11% | 4.428 SH | 05 Ottobre 2026 | Giornaliero |
| IWL · iShares Trust | 0,11% | 5.786 SH | 11 Settembre 2026 | Giornaliero |
| MGC · VANGUARD WORLD FUND | 0,11% | 31.176 SH | 19 Agosto 2026 | Giornaliero |
| ACIO · ETF Series Solutions | 0,11% | 6.205 NS | 31 Luglio 2026 | N-PORT |
| EVUS · iShares Trust | 0,10% | 934 SH | 11 Settembre 2026 | Giornaliero |
| ADME · ETF Series Solutions | 0,10% | 751 NS | 31 Luglio 2026 | N-PORT |
| XRMI · Global X Funds | 0,10% | 126 NS | 31 Luglio 2026 | N-PORT |
| XCLR · Global X Funds | 0,10% | 9 NS | 31 Luglio 2026 | N-PORT |
| XYLD · Global X Funds | 0,10% | 8.148 NS | 31 Luglio 2026 | N-PORT |
| XTR · Global X Funds | 0,10% | 12 NS | 31 Luglio 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,10% | 13.621 NS | 31 Luglio 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,10% | 25.167 SH | 05 Ottobre 2026 | Giornaliero |
| VV · VANGUARD INDEX FUNDS | 0,10% | 181.364 SH | 19 Agosto 2026 | Giornaliero |
| ESGV · VANGUARD WORLD FUND | 0,10% | 33.758 SH | 19 Agosto 2026 | Giornaliero |
| IVV · iShares Trust | 0,10% | 1.957.485 SH | 11 Settembre 2026 | Giornaliero |
| PTLC · Pacer Funds Trust | 0,10% | 7.919 NS | 31 Luglio 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 1.395 NS | 31 Luglio 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,10% | 877 SH | 05 Ottobre 2026 | Giornaliero |
| ILCB · iShares Trust | 0,10% | 2.915 SH | 11 Settembre 2026 | Giornaliero |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 1.794 SH | 02 Ottobre 2026 | Giornaliero |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 20.766 NS | 31 Luglio 2026 | N-PORT |
| IYY · iShares Trust | 0,09% | 6.693 SH | 11 Settembre 2026 | Giornaliero |
| VOTE · TCW ETF Trust | 0,09% | 2.545 NS | 31 Luglio 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,09% | 3.614 NS | 31 Luglio 2026 | N-PORT |
| XYLG · Global X Funds | 0,09% | 147 NS | 31 Luglio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,09% | 46.791 NS | 31 Luglio 2026 | N-PORT |
| IWB · iShares Trust | 0,09% | 103.721 SH | 11 Settembre 2026 | Giornaliero |
| VOO · VANGUARD INDEX FUNDS | 0,09% | 4.034.357 SH | 19 Agosto 2026 | Giornaliero |
| TOV · EA Series Trust | 0,09% | 607 NS | 31 Luglio 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,09% | 586 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,09% | 202.387 SH | 11 Settembre 2026 | Giornaliero |
| ACVF · ETF Opportunities Trust | 0,09% | 337 NS | 31 Luglio 2026 | N-PORT |
| GTOS · Invesco Actively Managed Exchange-T… | 0,09% | 104.000 | 05 Ottobre 2026 | Giornaliero |
| QDPL · Pacer Funds Trust | 0,09% | 3.708 NS | 31 Luglio 2026 | N-PORT |
| IWV · iShares Trust | 0,09% | 41.034 SH | 11 Settembre 2026 | Giornaliero |
| DFAU · Dimensional ETF Trust | 0,08% | 25.516 NS | 31 Luglio 2026 | N-PORT |
| CRBN · iShares Trust | 0,08% | 2.269 SH | 11 Settembre 2026 | Giornaliero |
| TOK · iShares Trust | 0,08% | 451 SH | 11 Settembre 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,08% | 4.930.930 SH | 19 Agosto 2026 | Giornaliero |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,08% | 24.633 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,08% | 12.577 SH | 19 Agosto 2026 | Giornaliero |
| PHDG · Invesco Actively Managed Exchange-T… | 0,08% | 116 SH | 05 Ottobre 2026 | Giornaliero |
| HCMT · Direxion Shares ETF Trust | 0,08% | 1.081 NS | 31 Luglio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,08% | 4.108 NS | 31 Luglio 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,07% | 12.141 NS | 31 Luglio 2026 | N-PORT |
| URTH · iShares, Inc. | 0,07% | 14.079 SH | 11 Settembre 2026 | Giornaliero |
| ACWI · iShares Trust | 0,06% | 50.294 SH | 11 Settembre 2026 | Giornaliero |
| HDUS · Lattice Strategies Trust | 0,05% | 275 NS | 31 Luglio 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,05% | 125.729 SH | 19 Agosto 2026 | Giornaliero |
| DCOR · Dimensional ETF Trust | 0,05% | 3.816 NS | 31 Luglio 2026 | N-PORT |
| GLOF · iShares Trust | 0,04% | 202 SH | 11 Settembre 2026 | Giornaliero |
| DUHP · Dimensional ETF Trust | 0,04% | 10.761 NS | 31 Luglio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 28.662 NS | 31 Luglio 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 1.127 NS | 31 Luglio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 99 NS | 31 Luglio 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 42.000 | 30 Settembre 2026 | Giornaliero |
| CBLS · Elevation Series Trust | -1,12% | -1.546 NS | 31 Luglio 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Luglio 2026 | Giornaliero |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Luglio 2026 | Giornaliero |
| VCEB · VANGUARD WORLD FUND | · | · | 30 Luglio 2026 | Giornaliero |
HCA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
Target Price a 12 Mesi
22 analisti · 2026-10-05Target medio $454.23 +5,1%
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | · |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | · |
| UHS | · | 9.4 | 9.7% | 8.6% | 21.4% | · |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | · |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | · |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | · |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | · |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | · |
Ultime notizie Notizie recenti che menzionano questa società
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Nessun segnale aperto al momento — nessuna scheda è compilata, e questo è onesto.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.